{
    "organizations": [],
    "uuid": "fdf339ef4a12abd13f75a6ec123c8be929f422fb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oasmia-pharmaceutical-q3-sales-ris/brief-oasmia-pharmaceutical-q3-sales-rise-smaller-operating-loss-idUSFWN1QK094",
    "ord_in_thread": 0,
    "title": "BRIEF-Oasmia Pharmaceutical Q3 sales rise, smaller operating loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 2 (Reuters) - Oasmia Pharmaceutical Ab:\n* Q3 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 656 COMPARED TO TSEK 36 IN Q3 PREVIOUS YEAR​\n* Q3 ‍OPERATING LOSS WAS TSEK 25,158 COMPARED TO TSEK 34,861 IN Q3 PREVIOUS YEAR​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)\n ",
    "published": "2018-03-02T15:33:00.000+02:00",
    "crawled": "2018-03-03T17:34:55.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "oasmia",
        "pharmaceutical",
        "ab",
        "q3",
        "net",
        "sale",
        "amounted",
        "tsek",
        "compared",
        "tsek",
        "q3",
        "previous",
        "q3",
        "loss",
        "tsek",
        "compared",
        "tsek",
        "q3",
        "previous",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "stockholm",
        "newsroom"
    ]
}